Product news

Share this article:
Johnson & Johnson's anemia drug Procrit has been linked to death in some patients, according to a new study. In the study, which was designed and initiated by a German scientist, more patients treated with Eprex (Procrit's name outside the US) died than in the comparison group receiving a placebo.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.